115 related articles for article (PubMed ID: 9724093)
61. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB; Michalopoulos GK
J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
[TBL] [Abstract][Full Text] [Related]
62. A sensitive screening assay for secreted motility-stimulating factors.
Nam SW; Clair T; Schiffmann E; Liotta LA; Stracke ML
Cell Motil Cytoskeleton; 2000 Aug; 46(4):279-84. PubMed ID: 10962482
[TBL] [Abstract][Full Text] [Related]
63. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
Sheng S; Carey J; Seftor EA; Dias L; Hendrix MJ; Sager R
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11669-74. PubMed ID: 8876194
[TBL] [Abstract][Full Text] [Related]
64. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
65. Prothrombin and its derivatives stimulate motility of melanoma cells.
Zhou H; Gabazza EC; Takeya H; Deguchi H; Urano H; Adachi Y; Suzuki K
Thromb Haemost; 1998 Sep; 80(3):407-12. PubMed ID: 9759619
[TBL] [Abstract][Full Text] [Related]
66. Insulin-like growth factors stimulate chemotaxis in human melanoma cells.
Stracke ML; Kohn EC; Aznavoorian SA; Wilson LL; Salomon D; Krutzsch HC; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1988 Jun; 153(3):1076-83. PubMed ID: 3291867
[TBL] [Abstract][Full Text] [Related]
67. Effects of cyclocreatine in rat hepatocarcinogenesis model.
Jeong KS; Park SJ; Lee CS; Kim TW; Kim SH; Ryu SY; Williams BH; Veech RL; Lee YS
Anticancer Res; 2000; 20(3A):1627-33. PubMed ID: 10928082
[TBL] [Abstract][Full Text] [Related]
68. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
Arioka M; Takahashi-Yanaga F; Kubo M; Igawa K; Tomooka K; Sasaguri T
Biochem Pharmacol; 2017 Aug; 138():31-48. PubMed ID: 28501501
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
70. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
71. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
72. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin.
Hayashido Y; Lucas A; Rougeot C; Godyna S; Argraves WS; Rochefort H
Int J Cancer; 1998 Feb; 75(4):654-8. PubMed ID: 9466671
[TBL] [Abstract][Full Text] [Related]
73. Effect of cyclocreatine feeding on levels of amino acids in rat hearts before and after an ischemic episode.
Osbakken M; Zhang DN; Nelson D; Erecińska M
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1919-26. PubMed ID: 1684269
[TBL] [Abstract][Full Text] [Related]
74. The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.
Stracke M; Liotta LA; Schiffmann E
Symp Soc Exp Biol; 1993; 47():197-214. PubMed ID: 8165565
[TBL] [Abstract][Full Text] [Related]
75. Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line.
Fallani A; Calorini L; Mannini A; Gabellieri S; Mugnai G; Ruggieri S
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):171-7. PubMed ID: 17085325
[TBL] [Abstract][Full Text] [Related]
76. Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility.
Chelberg MK; McCarthy JB; Skubitz AP; Furcht LT; Tsilibary EC
J Cell Biol; 1990 Jul; 111(1):261-70. PubMed ID: 2365734
[TBL] [Abstract][Full Text] [Related]
77. Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt.
Jeong JW; Jin CY; Park C; Han MH; Kim GY; Moon SK; Kim CG; Jeong YK; Kim WJ; Lee JD; Choi YH
Int J Oncol; 2012 May; 40(5):1697-704. PubMed ID: 22246470
[TBL] [Abstract][Full Text] [Related]
78. Modulation of tumor cell motility by plasmin.
Chikahisa L; Matsuo K; Yamada Y
Invasion Metastasis; 1997; 17(6):323-33. PubMed ID: 9949291
[TBL] [Abstract][Full Text] [Related]
79. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
Bonaccorsi L; Marchiani S; Muratori M; Forti G; Baldi E
J Cancer Res Clin Oncol; 2004 Oct; 130(10):604-14. PubMed ID: 15258753
[TBL] [Abstract][Full Text] [Related]
80. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
